APA (7th ed.) Citation

Z, Y., Z, L., C, Y., R, L., & Y, W. (2026). Design, synthesis and anti-Parkinson's disease bioactivity evaluation of isoquinoline derivatives as potent IDO1/TDO dual inhibitors. Bioorganic & medicinal chemistry letters, 136, 130596. https://doi.org/10.1016/j.bmcl.2026.130596

Chicago Style (17th ed.) Citation

Z, Yang, Lin Z, Yang C, Lu R, and Wu Y. "Design, Synthesis and Anti-Parkinson's Disease Bioactivity Evaluation of Isoquinoline Derivatives as Potent IDO1/TDO Dual Inhibitors." Bioorganic & Medicinal Chemistry Letters 136 (2026): 130596. https://doi.org/10.1016/j.bmcl.2026.130596.

MLA (9th ed.) Citation

Z, Yang, et al. "Design, Synthesis and Anti-Parkinson's Disease Bioactivity Evaluation of Isoquinoline Derivatives as Potent IDO1/TDO Dual Inhibitors." Bioorganic & Medicinal Chemistry Letters, vol. 136, 2026, p. 130596, https://doi.org/10.1016/j.bmcl.2026.130596.

Warning: These citations may not always be 100% accurate.